Fator do impacto:
2.9
FI de cinco anos:
3.72
SJR:
0.736
SNIP:
0.551
CiteScore™:
2.43
ISSN Imprimir: 0743-4863
Volumes:
|
Critical Reviews™ in Therapeutic Drug Carrier Systems
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i6.10
pages 447-485 Structuring Polymers for Delivery of DNA-Based Therapeutics: Updated Insights
Madhu Gupta
Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar-470003 M.P. India Nil
Shailja Tiwari
Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh 470003, India
Suresh P. Vyas
Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M. P., India, 470003 RESUMOGene therapy offers greater opportunities for treating numerous incurable diseases from genetic disorders, infections, and cancer. However, development of appropriate delivery systems could be one of the most important factors to overcome numerous biological barriers for delivery of various therapeutic molecules. A number of nonviral polymer-mediated vectors have been developed for DNA delivery and offer the potential to surmount the associated problems of their viral counterpart. To address the concerns associated with safety issues, a wide range of polymeric vectors are available and have been utilized successfully to deliver their therapeutics in vivo. Today's research is mainly focused on the various natural or synthetic polymer-based delivery carriers that protect the DNA molecule from degradation, which offer specific targeting to the desired cells after systemic administration, have transfection efficiencies equivalent to virus-mediated gene delivery, and have long-term gene expression through sustained-release mechanisms. This review explores an updated overview of different nonviral polymeric delivery system for delivery of DNA-based therapeutics. These polymeric carriers have been evaluated in vitro and in vivo and are being utilized in various stages of clinical evaluation. Continued research and understanding of the principles of polymer-based gene delivery systems will enable us to develop new and efficient delivery systems for the delivery of DNA-based therapeutics to achieve the goal of efficacious and specific gene therapy for a vast array of clinical disorders as the therapeutic solutions of tomorrow. Palavras-chave: gene therapy, polymeric vector, natural or synthetic polymers, transfection efficiencies
Articles with similar content:
Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 1 Amit K. Jain, Manasmita Das, Nitin K. Swarnakar, Sanyog Jain
Delivery of Biotherapeutics by Inhalation Aerosol
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.12, 1995, issue 2-3 Ralph W. Niven
Recent Progress in Polymeric Gene Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.20, 2003, issue 4 Sanjeev Kumar Mendiratta, Khursheed Anwer, B. G. Rhee
Polymeric Gene Carriers
Critical Reviews™ in Eukaryotic Gene Expression, Vol.15, 2005, issue 4 Han Chang Kang, You Han Bae, Minhyung Lee
Role of Block Copolymer Nanoconstructs in Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 2 H. G. Agrawal, K. K. Upadhyay, C. Schatz, Sebastian Lecommandoux, J. F. Le Meins, Ambikanandan Misra, C. Upadhyay |
Portal Digital Begell | Biblioteca digital da Begell | eBooks | Diários | Referências e Anais | Coleções de pesquisa |